Merck dives into COPD treatments with $10 billion purchase of Verona Pharma
-
Verona Pharma’s stock soars toward a record after $10 billion buyout deal
with Merck.
7 minutes ago
Social networking, and properties intangible or tangible.
For those just starting out, the most common fear is not competition or bankruptcy but a visit from corrupt officials, who go around soliciting bribes or offering paid protection, which is known as a krysha, or roof.
ReplyDeleteRead more: http://www.time.com/time/world/article/0,8599,2080414,00.html#ixzz1SSccWBdI